Shandong Weigao Group Medical Polymer Company Limited
Shandong Weigao Group Medical Polymer Company Limited
Your view on SHWGF
Overview
What the company does, where it operates, and who runs it.
About Shandong Weigao Group Medical Polymer Company Limited
- Industry
- Medical - Instruments & Supplies
- Sector
- Healthcare
- CEO
- Rinan Cong
- Headquarters
- Torch Hi-Tech Science Park, Weihai, CN
- Industry
- Medical - Instruments & Supplies
- Sector
- Healthcare
- CEO
- Rinan Cong
- Headquarters
- Torch Hi-Tech Science Park, Weihai, CN
Shandong Weigao Group Medical Polymer Company Limited engages in the research and development, production, and sale of single-use medical devices in the People's Republic of China. It operates through Medical Device Products, Orthopaedic Products, Interventional Products, Pharma Packaging Products, Blood Management Products, and Others segments.
The company offers vascular and non-vascular access infusion devices, infusion sets, syringes, puncture needles, and specialized single-use clinical collection kits; wound sutures, wound healing dressings, and wound cleaning and nonvascular catheter supporting extracorporeal devices; and blood collection, storage, separation, and sterilization equipment.
It also provides prefilled syringes and pre-filled flush syringes; blood collection and blood glucose testing devices; and general anesthesia consumables, local anesthesia consumables, anesthesia auxiliary consumables, ICU equipment, and open and minimally invasive surgical equipment.
In addition, the company engages in the production and sale of orthopedic devices; tumor and blood vessel interventional instruments; implantation materials and artificial organs; medical PVC granules, plastic packing bags, and carton boxes; industrial automatic equipment and parts; molds; hemodialysis equipment; and type I, type II, and type III medical devices.
Further, it is involved in the finance leasing and factoring business; wholesale of type I medical devices, surgical devices, and other disposal medical products; provision of asset management, enterprise consulting, enterprise management advisory services, as well as logistics and storage services, as well as export its products.
The company offers its products under the Jierui, Wego Ortho, Yahua, Bangde, and Hai Xing brands. It serves hospitals, blood stations, and other medical units; and distributors. The company was incorporated in 2000 and is based in Weihai, the People's Republic of China.
Media
Infographics, videos, and posts covering the company.
Stock Data
Price chart, volume, and trading data.
Fair Value
What FRC thinks it is worth vs. the current price.
FRC's fair value estimate for Shandong Weigao Group Medical Polymer Company Limited, and the rating behind it. SHWGF last traded at $0.73, 8.8× trailing earnings — the estimate is read against that market price. FRC analysts run the firm's valuation model across the companies on this platform to estimate what each one is worth, rather than republishing a consensus average. Shows the current estimate, our rating, and when it was last revised. A free account covers 7 company valuations a month; a paid subscription is unlimited.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
Valuation, profitability, liquidity and leverage ratios for Shandong Weigao Group Medical Polymer Company Limited. Starting points for Shandong Weigao Group Medical Polymer Company Limited: P/E 8.8, EPS $0.30, beta 0.20 — an Medical - Instruments & Supplies name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
Dividend history, yield and payout sustainability for Shandong Weigao Group Medical Polymer Company Limited. Shandong Weigao Group Medical Polymer Company Limited does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
Reported vs. expected earnings history for Shandong Weigao Group Medical Polymer Company Limited. Trailing twelve-month EPS for Shandong Weigao Group Medical Polymer Company Limited stands at $0.30. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Financial Statements
Income statement, balance sheet, and cash flow statements.
Income statement, balance sheet and cash flow history for Shandong Weigao Group Medical Polymer Company Limited. Shandong Weigao Group Medical Polymer Company Limited has reported as a listed company since 2010. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
Shandong Weigao Group Medical Polymer Company Limited valued side by side against its closest peers. Shandong Weigao Group Medical Polymer Company Limited is measured against Medical - Instruments & Supplies peers within the Healthcare sector. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.
Institutional Ownership
PremiumWhich funds and firms own the stock.
Which institutions hold Shandong Weigao Group Medical Polymer Company Limited, and how their positions are changing. At a $3.26B market value, institutional positions materially move Shandong Weigao Group Medical Polymer Company Limited's register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings. Included with FRC Premium.
Insider Trading
PremiumRecent buying and selling by company executives.
Buying and selling by Shandong Weigao Group Medical Polymer Company Limited executives and directors. Shares of Shandong Weigao Group Medical Polymer Company Limited have traded between $0.66 and $0.76 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned. Included with FRC Premium.
Senate Trading
PremiumU.S. Senator disclosures filed under the STOCK Act.
U.S. Senate disclosures naming Shandong Weigao Group Medical Polymer Company Limited. Shandong Weigao Group Medical Polymer Company Limited is a $3.26B Healthcare company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely. Included with FRC Premium.
House Trading
PremiumU.S. Representative disclosures filed under the STOCK Act.
U.S. House of Representatives disclosures naming Shandong Weigao Group Medical Polymer Company Limited. Representatives' reported transactions in this security, shown next to the company's fundamentals. Included with FRC Premium.
News
Latest headlines and market coverage.
Latest headlines and company announcements for Shandong Weigao Group Medical Polymer Company Limited. Coverage tracks Shandong Weigao Group Medical Polymer Company Limited within Medical - Instruments & Supplies (Healthcare). Press releases and market coverage, newest first.